Skip to main content
. 2018 Mar 14;35(5):841–849. doi: 10.1007/s10815-018-1155-z

Table 4.

Clinical outcomes of the untreated and treated groups in cycle 2 (n = 198)*

Untreated group (n = 158) IVM treated group (n = 40) Logistic regression OR (95% CI)++ Logistic regression AOR (95% CI)++***
No. patients with failed fertilization (% total) 11 (7.0%) 1 (2.5%) 0.36 (0.04-2.86) 0.17 (0.02-1.52)
Implantation rate (#sacs/# transferred)# 23.1% 20.3% 1.14 (0.71–1.83) 1.22 (0.72–2.09)
Cycle outcome
 No. freeze-all 8 (5.1%) 2 (5.0%) 0.97 (0.20–4.77) 0.70 (0.10–4.93)
 No. with transfer 139 (88.0%) 37 (92.5%) 1.65 (0.46–5.90) 3.26 (0.75–14.24)
 No. chemical/ectopic 31 (19.6%) 5 (12.5%) 0.58 (0.21–1.61) 0.59 (0.20–1.75)
 No. clinical pregnancy (with sac) 51 (32.3%) 14 (35.0%) 1.11 (0.53–2.32) 1.27 (0.57–2.84)
 No. to OB care+ 44 (27.9%) 12 (30.0%) 1.08 (0.50–2.32) 1.30 (0.56–3.03)
 No. live birth** 42 (26.8%) 12 (30.0%) 1.14 (0.53–2.45) 1.33 (0.57–3.11)

*PGD/PGS cycles excluded

#Poisson regression used

+Pregnancies that graduated to OB Care but that have not yet delivered

**Live births, calculated from n = 157

++OR odds ratio, CI confidence interval: comparing outcomes of cycle 2, adjusted for age

***AOR adjusted odds ratio adjusted for age, stimulation protocol, trigger type, hours to retrieval, and insemination type